日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A novel closure technique for a mucosal defect after endoscopic submucosal dissection: "closure on traction using a rotatable clip with a line loop"

一种用于内镜黏膜下剥离术后黏膜缺损的新型闭合技术:“使用带线环的旋转夹进行牵引闭合”

Ochiai, Yorinari; Oda, Minoru; Tanaka, Junji; Kawai, Yusuke; Yamato, Hiroshi; Suzuki, Yugo; Hoteya, Shu

Efficacy of Total-Body Irradiation-based Intensified Myeloablative Regimens for Acute Leukemia-An International Collaborative Study

全身照射强化清髓方案治疗急性白血病的疗效——一项国际合作研究

Arai, Yasuyuki; Brazauskas, Ruta; He, Naya; Al-Homsi, A Samer; Chhabra, Saurabh; Battiwalla, Minoo; Yanada, Masamitsu; Steinberg, Amir; Diaz Perez, Miguel Angel; Hong, Sanghee; Kanda, Junya; Bashey, Asad; Frangoul, Haydar A; Badawy, Sherif M; Verdonck, Leo F; Lazarus, Hillard M; Yared, Jean A; Hashem, Hasan; Sharma, Akshay; Aljurf, Mahmoud; Dias, Ajoy L; Abid, Muhammad Bilal; Wirk, Baldeep; Freytes, César O; Zeidan, Amer M; Gergis, Usama; Beitinjaneh, Amer; Askar, Medhat; Pu, Jeffrey J; Lehmann, Leslie E; Rangarajan, Hemalatha G; Wood, William A; Hashmi, Shahrukh; Yano, Shingo; Kako, Shinichi; Ozawa, Yukiyasu; Doki, Noriko; Kanda, Yoshinobu; Fukuda, Takahiro; Katayama, Yuta; Ichinohe, Tatsuo; Tanaka, Junji; Teshima, Takanori; Okamoto, Shinichiro; Atsuta, Yoshiko; Saber, Wael

Tyrosine kinase inhibitors modulate the expression of peroxiredoxins 1 and 2 in chronic myeloid leukemia cells

酪氨酸激酶抑制剂可调节慢性粒细胞白血病细胞中过氧化物酶1和2的表达。

Kazama, Hiroshi; Wang, Yan-Hua; Tanaka, Junji

Elotuzumab Enhances CD16-Independent NK Cell-Mediated Cytotoxicity against Myeloma Cells by Upregulating Several NK Cell-Enhancing Genes

埃洛妥珠单抗通过上调多个NK细胞增强基因,增强CD16非依赖性NK细胞介导的抗骨髓瘤细胞的细胞毒性

Yan-Hua Wang ,Shotaro Hagiwara ,Hiroshi Kazama ,Yuki Iizuka ,Norina Tanaka ,Junji Tanaka

Type 1 diabetes mellitus following COVID-19 vaccination: a report of two cases and review of literature

新冠疫苗接种后发生1型糖尿病:两例病例报告及文献综述

Mochizuki, Shota; Miura, Junnosuke; Ucida, Kiwako; Kubota, Ryo; Fujikawa, Hirona; Takagi, Satoshi; Yoshida, Naoshi; Ootake, Sachiko; Fujimori, Chika; Shinohara, Akihito; Tanaka, Junji; Babazono, Tetsuya

CMV reactivation after allogeneic HCT is associated with a reduced risk of relapse in acute lymphoblastic leukemia

异基因造血干细胞移植后巨细胞病毒再激活与急性淋巴细胞白血病复发风险降低相关。

Akahoshi, Yu; Nakasone, Hideki; Takenaka, Katsuto; Yamasaki, Satoshi; Nakamura, Momoko; Doki, Noriko; Tanaka, Masatsugu; Ozawa, Yukiyasu; Uchida, Naoyuki; Ara, Takahide; Nakamae, Hirohisa; Ota, Shuichi; Onizuka, Makoto; Yano, Shingo; Tanaka, Junji; Fukuda, Takahiro; Kanda, Yoshinobu; Atsuta, Yoshiko; Kako, Shinichi; Yanada, Masamitsu; Arai, Yasuyuki

Should a matched sibling donor still be considered the primary option for allogeneic hematopoietic cell transplantation in patients over 50 years of age with myelodysplastic syndrome?

对于 50 岁以上患有骨髓增生异常综合征的患者,同胞供体是否仍应被视为异基因造血干细胞移植的首选方案?

Konuma, Takaaki; Itonaga, Hidehiro; Ishiyama, Ken; Doki, Noriko; Uchida, Naoyuki; Sawa, Masashi; Katayama, Yuta; Tanaka, Masatsugu; Ueda, Yasunori; Onizuka, Makoto; Miyakoshi, Shigesaburo; Ozawa, Yukiyasu; Fukuda, Takahiro; Matsuoka, Ken-Ichi; Tanaka, Junji; Kimura, Takafumi; Ichinohe, Tatsuo; Atsuta, Yoshiko

Phase 2 results of idecabtagene vicleucel (ide-cel, bb2121) in Japanese patients with relapsed and refractory multiple myeloma

idecabtagene vicleucel(ide-cel,bb2121)治疗日本复发难治性多发性骨髓瘤患者的II期临床试验结果

Minakata, Daisuke; Ishida, Tadao; Ando, Kiyoshi; Suzuki, Rikio; Tanaka, Junji; Hagiwara, Shotaro; Ananthakrishnan, Revathi; Kuwayama, Shigeki; Nishio, Mitsufumi; Kanda, Yoshinobu; Suzuki, Kenshi

The efficacy of neutralizing monoclonal antibodies in transplant recipients with mild-to-moderate COVID-19

中和单克隆抗体对轻度至中度 COVID-19 移植受者的疗效

Arimura, Ken; Tagaya, Etsuko; Kikuchi, Ken; Mitsuda, Toshihiro; Ebihara, Fumiya; Maruyama, Takumi; Hamada, Yukihiro; Unagami, Kohei; Kanzawa, Taichi; Sekiguchi, Haruki; Shimamoto, Ken; Ishida, Hideki; Egawa, Hiroto; Tanaka, Junji; Kawana, Masatoshi

Improvements in allogeneic hematopoietic cell transplantation outcomes for adults with ALL over the past 3 decades

过去三十年来,成人急性淋巴细胞白血病(ALL)患者的异基因造血干细胞移植疗效有所改善

Nishiwaki, Satoshi; Akahoshi, Yu; Morita-Fujita, Mari; Shimizu, Hiroaki; Uchida, Naoyuki; Ozawa, Yukiyasu; Fukuda, Takahiro; Tanaka, Masatsugu; Ikegame, Kazuhiro; Ota, Shuichi; Katayama, Yuta; Takahashi, Satoshi; Kawakita, Toshiro; Ara, Takahide; Onizuka, Makoto; Kimura, Takafumi; Tanaka, Junji; Atsuta, Yoshiko; Arai, Yasuyuki